Gunter Brenner

Title: Gunter Brenner: Innovator in Hypolipidaemic Agents

Introduction

Gunter Brenner is a notable inventor based in Tannenweg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypolipidaemic agents. With a total of 3 patents, his work has had a meaningful impact on medical treatments.

Latest Patents

Brenner's latest patents include innovative compounds that serve as hypolipidaemic agents. One of his notable inventions is the "Theophylline salts of 5-methylisoxazole-3-carboxylic acid." This patent describes the salts of N-unsubstituted, N-monosubstituted, and N,N-disubstituted 7-(3-amino-2-hydroxypropyl)theophylline and 5-methylisoxazole-3-carboxylic acid. These compounds are prepared by allowing the isoxazole acid and the amine to react. Another significant patent is for "Esters of the ophyllinylacetic acid," which includes a compound formula where R is hydrogen or methyl, and n is a number from 1 to 4. These compounds are particularly useful for their effects on serum lipoids and for treating adverse hyperlipidemic states in humans.

Career Highlights

Throughout his career, Gunter Brenner has focused on the development of pharmaceutical compounds that address critical health issues. His innovative approach has led to the creation of effective treatments that contribute to better health outcomes.

Collaborations

Brenner has collaborated with notable colleagues in his field, including Manfred Tauscher and Karl Credner. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical innovations.

Conclusion

Gunter Brenner's contributions to the field of pharmaceuticals, particularly in the area of hypolipidaemic agents, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving health outcomes.